Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Rossari Biotech completes first 76% tranche of Tristar acquisition
Rossari Biotech completed the acquisition of the first tranche, representing 76% of Tristar Intermediates’ equity share capital, on 1 September 2021. The source says Rossari is to acquire the remaining 24% over the next three years.
2020
Rossari Biotech announces Group CFO appointment
Rossari Biotech announced Manikantan Viswanathan's appointment as Group Chief Financial Officer, effective October 26, 2020.